Palivizumab

Category: Vaccination



Palivizumab Overview

Palivizumab, sold under the brand name Synagis, is a monoclonal antibody produced by recombinant DNA technology.[2] It is used in the prevention of respiratory syncytial virus (RSV) infections.[2][3] It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease.[2][3] The most common side effects include fever and rash.[3][...

Read more Palivizumab Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Palivizumab

Recent Palivizumab Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Palivizumab
  • Injection: 100mg, 100mg/ml, 50mg, 50mg/ml
  • Vial: 100mg/vial, 50mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Palivizumab or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 28 October 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA